Catheter Encrustation: Causes, Prevention, and Impact

Catheter encrustation is a buildup of mineral crystals on the inner and outer surfaces of urinary catheters, driven primarily by bacteria that raise the pH of urine until dissolved minerals solidify into a hard crust. It is one of the most common and frustrating complications of long-term catheterization, and in a year-long study of people with indwelling catheters, roughly a third experienced at least one blockage episode, with some individuals reporting dozens or even well over a hundred blockages in that period.¹ Understanding what triggers encrustation, who it affects most, and what can realistically be done about it makes a meaningful difference for catheter users and their caregivers.

How Encrustation Happens

The process starts with certain bacteria that produce an enzyme called urease. When these organisms colonize the catheter and surrounding urine, urease breaks down urea (a normal waste product in urine) into ammonia. That ammonia drives the urine’s pH sharply upward, turning it alkaline. Once the pH climbs high enough, calcium and magnesium salts that would normally stay dissolved begin to crystallize out of solution and deposit on the catheter surface.² The crystals embed themselves within a sticky bacterial biofilm, and as the layers accumulate, the catheter’s drainage channel narrows and eventually blocks.

The chief bacterial culprit is Proteus mirabilis, a species notorious for forming dense crystalline biofilms that can completely occlude urine flow.³ Other urease producers, including Providencia stuartii, also play a role. In one nursing-home study following catheterized women over several months, the patients whose catheters repeatedly blocked were significantly more likely to harbor Proteus mirabilis and Providencia stuartii, and significantly less likely to carry non-urease-producing species like Klebsiella pneumoniae.⁴ When two of those chronic blockers happened to lose their Proteus colonization during unrelated antibiotic treatment, their catheters stopped blocking entirely.

What the Deposits Are Made Of

The mineral crust is not a single substance. Studies using X-ray diffraction and electron microscopy consistently identify two main components. The first is struvite, a crystalline magnesium ammonium phosphate that forms relatively large, easily recognizable crystals.⁵ The second is hydroxyapatite, a calcium phosphate that tends to precipitate in a poorly crystalline form and clumps together into a hard crust rather than forming neat individual crystals.⁶ In some samples, struvite is the only mineral clearly visible on X-ray, but chemical analysis reveals calcium phosphate hiding alongside it in a disordered form that is harder to detect.⁷

Both minerals form because of the same upstream event: the pH spike caused by bacterial urease. That shared trigger is why prevention efforts tend to focus on either killing the bacteria, inhibiting the enzyme, or keeping the pH from rising, rather than targeting one mineral specifically.

Blockers, Intermediates, and Non-Blockers

One of the more striking findings in this area is that not all catheterized patients experience encrustation equally. Researchers categorized patients into “blockers” (frequent encrustation and blockage), “intermediates,” and “non-blockers,” and found that individuals tended to stay in their category consistently over time.⁸ Blockers excrete more alkaline urine and, somewhat counterintuitively, have lower concentrations of magnesium, urea, and phosphate in their urine. The consistent presence of urease-producing bacteria appears to be the defining factor.

Beyond bacterial colonization, several dietary and metabolic factors contribute to encrustation risk. These include excess calcium from protein supplements or antacids, extra magnesium from certain beverages, alkali from effervescent tablets, and even intermittent dehydration caused by alcohol. Less avoidable factors include the increased calcium excretion that comes with immobility and excessive sweating that concentrates urine.⁹ For people who use wheelchairs or spend long periods in bed, both of those harder-to-modify risk factors are common realities.

When a Blocked Catheter Becomes Dangerous

A blocked catheter is never just an inconvenience. When urine cannot drain, the bladder distends, and pressure backs up toward the kidneys. In case reports, patients with encrusted or malpositioned catheters developed acute kidney injury that reversed rapidly once the blocked catheter was replaced.¹⁰ The speed of recovery after catheter replacement suggests the kidneys themselves are not permanently damaged in most short-duration blockages, but the risk is real if the obstruction goes unnoticed.

For people with spinal cord injuries, particularly those with lesions above the mid-thoracic level, a blocked catheter carries a distinct and potentially life-threatening risk. The distended bladder triggers autonomic dysreflexia, a runaway response of the nervous system that can cause sudden severe headaches, dangerous spikes in blood pressure, sweating, irregular heart rhythms, seizures, and in the worst cases, brain hemorrhage or acute lung swelling.¹¹ For this population, prompt recognition and replacement of a blocked catheter is an emergency-level priority.

Blockage also appears to be linked to catheter-associated urinary tract infections. In the year-long study of long-term catheter users mentioned earlier, catheter blockage was a marginally significant predictor of infection, with roughly a 50% increase in the odds of developing a catheter-associated urinary tract infection after a blockage episode.¹ The same study documented that sediment in the catheter drainage was reported by nearly nine in ten participants, and leakage or bypassing by two-thirds, painting a picture of catheter problems that are pervasive, not occasional.

How Catheter Material Affects Encrustation

Not all catheter surfaces attract crystals at the same rate. In patients classified as blockers, silicone catheters developed significantly less encrustation and blockage than Teflon-coated or plain latex catheters. The advantage appeared partly related to the larger internal bore of silicone catheters, which allows faster urine flow even as some deposits form.¹² For patients who are not chronic blockers, however, the material difference is less meaningful, and a cheaper catheter changed more frequently can be a reasonable alternative.

Hydrogel-coated latex catheters have shown promise in some studies, with one finding that the hydrogel coating effectively prevented encrustation while siliconised latex was the least resistant.¹³ But the picture is not clear-cut: a separate laboratory comparison found no significant difference in encrustation between silicone and hydrogel-coated latex.¹⁴ The inconsistency probably reflects differences in testing conditions and the fact that in real patients, bacterial colonization and urine chemistry matter more than catheter surface alone.

Silver-based coatings represent a newer approach. A silver-polytetrafluoroethylene nanocomposite coating more than doubled the time to blockage in laboratory models, extending it from about 36 hours to roughly 90 hours. The coating resisted encrustation even though it did not dramatically change the bacteria’s ability to raise urine pH, suggesting it works by making the surface physically less hospitable to crystal adhesion.¹⁵ Experimental multi-layered silver nanoparticle coatings have pushed resistance even further, with one design resisting encrustation for up to 45 days compared to about six days for a commercially available silver-coated catheter.¹⁶ These are laboratory results, so real-world durability may differ, but the gap between experimental and commercial performance suggests there is substantial room for improvement in what is currently available.

Urease Inhibitors and Bladder Washouts

Since the entire encrustation cascade depends on urease raising urine pH, blocking that enzyme is a logical strategy. Acetohydroxamic acid (AHA), a urease inhibitor, reduced catheter encrustation by an average of about 80% in a clinical study, and patients on the drug needed catheter changes less frequently.¹⁷ Laboratory work has confirmed that AHA and another urease inhibitor, fluorofamide, both restrict the pH rise caused by Proteus mirabilis infection, with fluorofamide effective at a much lower concentration.¹⁸ More recent research has explored combining AHA with naturally occurring metabolites from the urinary tract, finding synergistic effects that could allow lower drug doses while maintaining prevention.¹⁹

Bladder washouts with acidic solutions are a more hands-on clinical intervention. Irrigating with a citric acid solution (sometimes called Suby G) dissolved about 70% of existing encrustation in laboratory tests and restored normal flow rates through the catheter.²⁰ Further work showed that two sequential washouts with 50 mL of acidic solution were more effective than a single larger washout, suggesting that technique matters as much as volume.²¹ Washouts can buy time and reduce the frequency of emergency catheter changes, but they treat the symptom rather than the underlying bacterial problem.

Citrated Drinks and Fluid Intake

For patients managing encrustation at home, simpler interventions can help. A randomized crossover trial tested three strategies: drinking lemon juice diluted in water, simply increasing fluid intake, and taking potassium citrate supplements. All three raised the “nucleation pH,” which is the pH at which crystals begin forming, effectively pushing the threshold higher and giving a wider safety margin before encrustation can start. Lemon juice produced the largest increase in that safety margin, followed by increased fluid intake and then potassium citrate.²² Citrated drinks work in two ways: the citrate itself inhibits crystal formation, and the extra fluid dilutes the minerals in urine, making them less likely to precipitate.

These strategies are not a cure, but as a practical stopgap for people who block frequently, they are inexpensive and low-risk. Increasing fluid intake with citrated drinks has been specifically recommended as a bridging measure for patients waiting for procedures like bladder stone removal.²³ Patients should be aware, however, that excessive citrate from concentrated fruit juices can paradoxically contribute to encrustation in some circumstances, so moderation and guidance from a clinician is sensible.⁹

Early Warning Sensors

One of the most frustrating aspects of encrustation is that a catheter can look fine from the outside right up until it blocks completely. Researchers have developed a simple sensor designed to detect the early stages of the problem by responding to the pH change in urine that precedes crystal formation. In laboratory models, the sensor signaled encrustation an average of 43 hours before the catheter actually blocked.²⁴

In clinical testing, the sensor performed well at distinguishing patients colonized with Proteus mirabilis from those without it. In patients harboring the organism, the sensor consistently turned dark blue or black, and all of their catheters showed encrustation; in patients without Proteus, the sensor stayed golden-yellow and their catheters were clean. The average time between the sensor changing color and the catheter actually blocking was 12 days, which would give patients and carers a useful window to arrange a catheter change before an emergency.²⁵ A later evaluation noted that while the sensor is useful as an indicator of high-risk urine conditions, the time between the color change and actual blockage still varies enough that it works better as a clinical aid than as a precise alarm.²⁶

The Cost of Encrustation-Related Problems

Catheter complications are expensive, both in healthcare spending and in the burden on patients and emergency departments. A population-based analysis in England found that the mean annual cost of health services used by community catheter patients was about £1,190, but that figure was heavily skewed: about 14% of users accounted for half of all costs, largely driven by hospital admissions in a subset of patients who experienced frequent complications.²⁷ A Swedish study of nursing-home patients found that personnel time accounted for over 90% of the costs tied to indwelling catheters, with acute interventions for problems like blockage adding substantially to the baseline.²⁸

Blocked catheters are also a significant driver of emergency department visits. Over a 69-day period at one hospital, 78 patients presented to the emergency department with a catheter problem, and nearly half of those visits were for a blocked catheter. Two-thirds of the patients had long-term catheters, and many of the visits could have been avoided with better community catheter care services.²⁹ For patients, each emergency visit for a blocked catheter means pain, disruption, potential hospitalization, and often a sense that the healthcare system is reacting to crises rather than preventing them.

Why Flow Dynamics Shape Where Crystals Form

An area of active research that could reshape catheter and stent design involves understanding the physics of urine flow inside these devices. Crystals do not form uniformly along a catheter’s surface. They accumulate preferentially in zones where the flow of urine is slow or stagnant, because moving fluid exerts a shearing force on the surface that helps sweep away particles before they can settle and adhere. In experiments using microfluidic “stent-on-chip” models, areas with near-stagnant flow and very low wall shear stress had the highest encrustation rates, while regions where urine flowed faster and exerted more shear stayed relatively clean.³⁰ Increasing the drainage flow rate from 1 to 10 mL per minute significantly reduced crystal deposition across the board.

This relationship between shear stress and encrustation has been confirmed by computational fluid dynamics simulations paired with physical experiments. In one study comparing different ureteral stent designs, the stent type that generated the highest wall shear stress near a narrowed region showed the lowest encrustation coverage and the smallest gain in deposited mass.³¹ Reviews of these experimental and computational findings reinforce that low-shear zones are the most critical regions for both biofilm growth and crystal accumulation.³² The practical implication is that future catheter designs could reduce encrustation not by adding chemical coatings but by rethinking the geometry of drainage holes and internal channels to eliminate dead zones where crystals like to grow.

Bacteriophage Therapy and Infection-Responsive Coatings

One of the more inventive approaches to encrustation involves using bacteriophages, viruses that specifically infect and kill bacteria, delivered directly from the catheter surface. Researchers have developed a dual-layered coating that sits dormant until the pH of urine starts rising, indicating that Proteus mirabilis has begun colonizing. Once the pH hits the trigger point, the outer layer dissolves and releases a burst of phage from the reservoir underneath. In an in vitro bladder model simulating established infection, this coating doubled the time before the catheter blocked.³³ The appeal of this approach is that it is self-activating: the coating releases its payload only when the problematic bacteria are present, which could minimize resistance development and avoid unnecessary antimicrobial exposure.

This work remains at the laboratory stage. Separate research has also demonstrated that phage can prevent encrustation and blockage by Proteus mirabilis in bladder models, though the authors acknowledged there are presently no truly effective clinical approaches to control catheter blockage by this organism.³ The gap between laboratory promise and bedside availability is familiar in catheter research, where many clever solutions have been demonstrated in models but stalled before reaching patients. For a problem that affects millions of catheter users worldwide, bridging that gap would be a significant advance.